Overview

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study compares the effectiveness and safety of the combination of anidulafungin and voriconazole compared to that of voriconazole alone (which is generally considered the standard of care) for the treatment of Invasive Aspergillosis.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Anidulafungin
Echinocandins
Voriconazole